Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: Effect of experimental conditions and a comparison with other enhancement strategies

European Journal of Pharmaceutical Sciences

Volumn 39, Issue 5, 2010, Pages 387-393

  Cázares Delgadillo, Jennyfer ^a   Ganem Rondero, Adriana ^b   Quintanar Guerrero, David ^b   López Castellano, Alicia C ^c   Merino, Virginia ^d   Kalia, Yogeshvar N ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Electromigration; Electroosmosis; Granisetron; Iontophoresis; Transdermal

Indexed keywords

GRANISETRON; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITY GRADIENT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG STABILITY; DRUG STRUCTURE; DRUG TRANSPORT; ELECTROOSMOSIS; FEASIBILITY STUDY; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; IONTOPHORESIS; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; TRANSPORT KINETICS;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIEMETICS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GRANISETRON; HALF-LIFE; IONTOPHORESIS; LIMIT OF DETECTION; MALE; RATS; RATS, WISTAR; SEROTONIN ANTAGONISTS; SKIN; SWINE;

EID: 77549083136     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.01.008     Document Type: Article

References (22)

1. Bopanna V.K. Simultaneous determination of granisetron and its 7-hydroxymetabolite in human plasma by reversed-phase high-performance liquid chromatography utilizing fluorescence and electrochemical detection. J. Chromatogr. A 692 (1995) 195-202
2. Chaturvedula A., Joshi D.P., Anderson C., Morris R., Sembrowich W.L., and Banga A.K. Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery. Pharm. Res. 22 (2005) 1313-1319
3. De Muth J.E. Basic Statistics and Pharmaceutical Statistical Applications (1999), Marcel Dekker, New York
4. Dimas D.A., Dallas P.P., and Rekkas D.M. Ion pair formation as a possible mechanism for the enhancement effect of lauric acid on the transdermal permeation of ondansetron. Pharm. Dev. Technol. 9 (2004) 311-320
5. Ding P., Yu H., Wei G., and Zheng J. Microdialysis sampling coupled to HPLC for transdermal delivery study of ondansetron hydrochloride in rats. Biomed. Chromatogr. 14 (2000) 141-143
6. Food and Drug Administration, 2001. Center for Veterinary Medicine. Guidance for Industry Bioanalytical Method Validation.
7. Gupta S.K., Southam M., Sathyan G., and Klausner M. Effect of current density on pharmacokinetics following continuous or intermittent input from a fentanyl electrotransport system. J. Pharm. Sci. 87 (1998) 976-981
8. Gwak H.S., Oh I.S., and Chun I.K. Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers. Drug Dev. Ind. Pharm. 30 (2004) 187-194
9. Hussain A.A., Dakkuri A., and Itoh S. Nasal absorption of ondansetron in rats: an alternative route of drug delivery. Cancer Chemother. Pharmacol. 45 (2000) 432-434
10. Kalia Y.N., Naik A., Garrison J., and Guy R.H. Iontophoretic drug delivery. Adv. Drug. Deliv. Rev. 56 (2004) 619-658
11. Kankkunen T., Sulkava R., Vuorio M., Kontturi K., and Hirvonen J. Transdermal iontophoresis of tacrine in vivo. Pharm. Res. 19 (2002) 705-708
12. Kasting G.B. Theoretical models for iontophoretic delivery. Adv. Drug Deliv. Rev. 9 (1992) 177-199
13. Kasting G.B., and Keister J.C. Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin. J. Control Rel. 8 (1989) 195-210
14. Kim Y.-C., Late S., Banga A.K., Ludovice P.J., and Prausnitz M.R. Biochemical enhancement of transdermal delivery with magainin peptide: modification of electrostatic interactions by changing pH. Int. J. Pharm. 362 (2008) 20-28
15. Krishnaiah Y.S., Rama B., Raghumurthy V., Ramanamurthy K.V., and Satyanarayana V. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes. Pharm. Dev. Technol. 14 (2009) 50-61
16. Lau D.T.W., Sharkey J.W., Petryk L., Mancuso F.A., Yu Z., and Tse F.L.S. Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin\) in the rabbit. Pharm. Res. 11 (1994) 1742-1746
17. Li G.L., van der Geest R., Chanet L., van Zanten E., Danhof M., and Bouwstra J.A. In vitro iontophoresis of apomorphine across human stratum corneum: the structure/transport relationship of penetration enhancement. J. Control Rel. 84 (2002) 49-57
18. Phipps J.B., and Gyory J.R. Transdermal ion migration. Adv. Drug Deliv. Rev. 9 (1992) 137-176
19. Singh P., Boniello S., Liu P., and Dinh S. Transdermal iontophoretic delivery of methylphenidate HCl in vivo. Int. J. Pharm. 178 (1999) 121-128
20. Sintov A.C., Krymberk I., Daniel D., Hannan T., Sohn Z., and Levin G. Radiofrequency-driven skin microchanneling as a new was for electrically assisted transdermal delivery of hydrophilic drugs. J. Control Rel. 89 (2003) 311-320
21. In: Sweetman S. (Ed). Martindale: The Complete Drug Reference (electronic version). 33rd edition (2003), Pharmaceutical Press, London
22. Takahashi K., and Rytting J.H. Novel approach to improve permeation of ondansetron across shed snake skin as a model membrane. J. Pharm. Pharmacol. 53 (2001) 789-794